TP53 and plasma cell leukemia: TP53 mutations were negatively associated with hyperdiploid status (no hyperdiploid cases among the TP53-mutated ones versus 33% in the entire cohort, P = 0.009); the over-representation of PCL patients within mutated cases could affect these findings, although in part confirmed in other series [30].